The AIM2-mediated noncanonical inflammasome activation could induce the release of IL-1α, a cytokine responsible for the release of TGF-β from the peripheral blood mononuclear cells (PBMCs) of patients with IPF [85]. The gene discussed is AIM2; the disease is idiopathic pulmonary fibrosis.